Cure JM Foundation Highlights

Thanks to the Juvenile Myositis community, family and friends, since our founding in 2003, Cure JM has

  • Invested over $19 million in research, education, and family support, making Cure JM the largest funder of Juvenile Myositis research in the world.
  • Funded over 180 defining research studies that have resulted in improved treatments and moved us closer to a cure.
  • Created resources and connections for over 4,000 patients and families in 40 different countries
  • Currently funding research at 24 prestigious research institutions in 4 countries.
  • Created and provided financial support to five Centers of Excellence to advance research and deliver world-class care at George Washington University Hospital, Lurie Children’s Hospital, Seattle Children’s Hospital, Duke Children’s Hospital, and University of California San Francisco.
  • Developed a Medical Advisory Board of the leading JM experts in the world
  • Funded breakthrough genetic studies at the renowned Center for Applied Genomics at Children’s Hospital of Philadelphia to understand the complex genetics of JM, which is critical to identifying targets for improved drug interventions.
  • Identified new drug candidates through the Cure JM-funded drug discovery project at the National Center for Advancing Translational Sciences at NIH.
  • Engaged with 19,000+ followers in our social media communities.
  • Created more than 20 regional chapters across the U.S.
  • Created support network for parents to learn from other parents
  • Implemented peer-mentorship program for older teens to mentor younger teens living with JM
  • Funded a research study with Duke University and CARRA to determine the best treatment approaches for JM.
  • Funded the first-ever book about JM, Myositis and You. Join Cure JM to receive a complementary digital copy.
  • Host annual Global Symposium on Myositis for clinicians and researchers
Doctor and young juvenile myositis patient.

What is Juvenile Myositis?

Juvenile myositis, including juvenile dermatomyositis and juvenile polymyositis, is a group of rare and life-threatening autoimmune diseases, in which the body’s immune system attacks its own cells and tissues.

Join Cure JM

Membership is free and we’ll connect you with a network of support, encouragement, and resources.

Cure JM supports families, patients, and the juvenile myositis research community.